Clinical Trial Update: REPRISE II: REpositionable Percutaneous Replacement of Stenotic Aortic Valve Through Implantation of Lotus™ Valve System [NA]

View source ↗

Summary

A completed clinical trial update for the REPRISE II study evaluating repositionable percutaneous replacement of a stenotic aortic valve using the Lotus Valve S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis
• Heart Valve Disease

Drugs mentioned

• Lotus Valve System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Transcatheter Aortic Valve Replacement | NA | Status: COMPLETED | Results posted: 2019-09-10